[Medlife]12(S)-HETrE(solution)|72710-10-2
简介:12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA). 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.英文名称:12(S)-HETrE
简介:12(S)-HETrE is produced by 12-lipoxygenase oxidation of dihomo-γ-linolenic acid (DGLA). 12(S)-HETrE is reported to inhibit agonist-mediated platelet activation (IC50 = 40 µM), α granule secretion, integrin αIIbβ3 activation, Rap1 activation, and thrombin-induced clot retraction in vitro.
12(S)-HETrE物理化学性质:
密度 | 1.0±0.1 g/cm3 |
---|---|
沸点 | 487.4±33.0 °C at 760 mmHg |
分子式 | C20H34O3 |
分子量 | 322.482 |
闪点 | 262.7±21.9 °C |
精确质量 | 322.250793 |
LogP | 5.94 |
蒸汽压 | 0.0±2.8 mmHg at 25°C |
折射率 | 1.502 |
12(S)-HETrE详细介绍:
英文名称: | 12(S)-HETrE(solution) |
英文别名: | 12(S)-HETrE;12S-HETrE;Q27163000 |
CAS号: | 72710-10-2 |
分子式: | C20H34O3 |
分子量: | 322.48 |
详细描述 | 12(S)-HETrE |
Medlife品牌是国内知名的小分子化合物品牌,致力于信号通路、抑制剂、激动剂等产品的研发及产品供应服务,同时还可提供重组蛋白、植提、寡核苷酸等系列的产品。
本文引用地址:https://www.canspec.cn/product/899363.html